Genentech / Roche obtain approval for Lucentis to treat DME
Roche (SIX: RO, ROG; OTCQX: RHHBY) have announced the FDA approval of Lucentis (ranibizumab injection) 0.3mg for the treatment of diabetic macular edema (DME). The… Read More »Genentech / Roche obtain approval for Lucentis to treat DME